Self-Renewal as a Therapeutic Target in Human Colorectal Cancer Researchers demonstrated that tumor formation and, more specifically, human colorectal cancer-initiating cell function are dependent on the canonical self-renewal regulator BMI-1. [Nat Med] Abstract | Press Release | Video Interview An In Vivo RNAi Screen Identifies SALL1 as a Tumor Suppressor in Human Breast Cancer with a Role in CDH1 Regulation Scientists showed that inhibition of SALL correlates with reduced levels of CDH1, an important contributor to epithelial-to-mesenchymal transition. Furthermore, SALL1 expression led to an increased migration and more than twice as many cells expressing a cancer stem cell signature. [Oncogene] Full Article LGR5 Positivity Defines Stem-Like Cells in Colorectal Cancer Silencing of leucine-rich-repeat-containing G-protein-coupled receptor 5 (LGR5) in SW480 colorectal carcinoma cells resulted in a depletion of spheres but did not affect adherently growing cells. Spheres expressed higher levels of several stem cell-associated genes than adherent cells, including LGR5. [Carcinogenesis] Abstract Prostaglandin E Receptor EP4 Is a Therapeutic Target in Breast Cancer Cells with Stem-Like Properties Treatment of mammosphere-forming cells with Prostaglandin E receptor 4 (EP4) inhibitors (RQ-15986, AH23848, Frondoside A) or EP4 gene silencing, but not with a cyclooxygenase inhibitor (Indomethacin) reduces both mammosphere-forming capacity and the expression of phenotypic markers (CD44hi/CD24low, aldehyde dehydrogenase) of breast cancer stem cells. [Breast Cancer Res Treat] Full Article Prognostic Value of Cancer Stem Cell Marker Aldehyde Dehydrogenase in Ovarian Cancer: A Meta-Analysis Investigators aimed to evaluate the association between the expression of aldehyde dehydrogenase and the outcome of ovarian cancer patients by performing a meta-analysis. [PLoS One] Full Article Differential Effects of Drugs Targeting Cancer Stem Cell (CSC) and Non-CSC Populations on Lung Primary Tumors and Metastasis Researchers investigated the effect of salinomycin, a selective inhibitor of CSCs, with or without combination with paclitaxel, in a metastatic model. [PLoS One] Full Article The Novel Myxofibrosarcoma Cell Line MUG-Myx1 Expresses a Tumorigenic Stem-Like Cell Population with High Aldehyde Dehydrogenase 1 Activity A stem-like cell population with high enzymatic activity of aldehyde dehydrogenase 1 was isolated for the first time from myxofibrosarcoma cells using the ALDEFLUOR® assay followed by FACS analysis. [BMC Cancer] Abstract | Full Article In Vitro and In Vivo Expression of Aldehyde Dehydrogenase 1 in Oral Squamous Cell Carcinoma Scientists investigated whether alterations in Aldehyde dehydrogenase isoform 1 immunostaining and enzymatic activity in tumor cell populations predicted clinicopathological factors of prognostic importance for cancer progression and contributed to the characteristics of cancer-initiating cells in cisplatin-treated oral squamous cell cancer cells. [Int J Oncol] Abstract |